1. Adams, M.J., Jr., J. R. Allen, A.T.L. Chen, G.P. Oakley Jr., and G.R. Noble. 1988. Diagnostic nucleic acids: A federal perspective. in:Nucleic Acid Probes in Diagnosis of Human Genetic Diseases.(Ed., A.M. Willey) Liss, New York, pp. 243–256.
2. Bangham, D.R. 1986. Scientific aspects of the licensing and control of products made by r-DNA procedures.Br. Inst. Reg. Affairs J.5:20–23.
3. Carstensen, J.T. and C.T. Rhodes. 1986. Cyclic testing in stability programs.Drug Develop. Indust. Pharm.12:1219.
4. Donlon, J.A. 1988. A regulatory perspective. in:Nucleic Acid Probes in Diagnosis of Human Genetic Diseases.(Ed., A.M. Willey) Liss, New York, pp. 257–263.
5. Edwards, R. 1993. Competing in drug safety.Science342:631–632.